Form 4 for BDSX BIODESIX INC
Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-23 · accession 0000905148-24-001616 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-23 | 2024-05-23 | BDSX | Vazquez Chris | CAO | M - OptEx | — | +880 | 10.8K | +9% | — |
| D | 2024-05-23 | 2024-05-23 | BDSX | Vazquez Chris | CAO | M - OptEx | $0.00 | -22 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-23 | M | A | 880 | — | 10,795 | D | — | — | (F1) The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024. |
| 2 | Derivative | Series A Non-Voting Convertible Preferred Stock | 2024-05-23 | M | D | 22 | $0.00 | 0 | D | — · — to — | 880 Common Stock | (F1) The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024. |